Phyto Chem (I)

  • Market Cap: Micro Cap
  • Industry: Pesticides & Agrochemicals
  • ISIN: INE037C01010
  • NSEID:
  • BSEID: 524808
INR
31.49
2.66 (9.23%)
BSENSE

Dec 05

BSE+NSE Vol: 126

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

126 (-92.72%) Volume

Shareholding (Sep 2025)

FII

0.00%

Held by 0 FIIs

DII

4.63%

Held by 0 DIIs

Promoter

40.40%

Who are the top shareholders of the Phyto Chem (I)?

06-Jun-2025

The top shareholder of Phyto Chem (I) is promoter Nayudamma Yarlagadda, holding 7.87%. Individual investors own 49.29% of the shares, with no pledged promoter holdings or foreign institutional investors involved.

The top shareholders of Phyto Chem (I) include Nayudamma Yarlagadda, who is the promoter with the highest holding at 7.87%. The majority of the shareholding is held by individual investors, accounting for 49.29% of the shares. There are no pledged promoter holdings, and the company has no foreign institutional investors (FIIs) involved. Additionally, two mutual fund schemes hold a small portion of shares, totaling 0.19%.

Read More

What does Phyto Chem (I) do?

06-Jun-2025

Phyto Chem (India) Ltd manufactures and markets pesticides for the agriculture sector. As of March 2025, it reported net sales of 1 Cr and a net loss of 1 Cr, with a market cap of Rs 12 Cr.

Overview: <BR>Phyto Chem (India) Ltd is engaged in the manufacturing and marketing of pesticides for the agriculture sector and operates within the Micro Cap category in the Pesticides & Agrochemicals industry.<BR><BR>History: <BR>Established in January 1989, Phyto Chem (India) Ltd has been involved in the pesticides business since its inception. The latest quarterly results reported are for March 2025, showing net sales and profit figures.<BR><BR>Financial Snapshot: <BR>Net Sales: 1 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: -1 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: Rs 12 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: N/A <BR>Industry P/E: 38 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 2.45 <BR>Return on Equity: -13.59% <BR>Price to Book: 1.65<BR><BR>Contact Details: <BR>Address: Survey No 628 Temple Street, Jinnaram Mandal Bonthapally Medak Telangana : 502313 <BR>Tel: 91-8458-275236 <BR>Email: info@phytochemindia.com <BR>Website: http://www.phytochemindia.com

Read More

Who are in the management team of Phyto Chem (I)?

06-Jun-2025

As of March 2022, the management team of Phyto Chem (I) includes Chairman P Sreemannarayana, Managing Director Y Nayudamma, and several directors, including both executive and independent members, totaling twelve key individuals.

As of March 2022, the management team of Phyto Chem (I) includes the following members:<BR><BR>1. P Sreemannarayana - Chairman (Non-Executive)<BR>2. Y Nayudamma - Managing Director<BR>3. Y Venkateswarlu - Director<BR>4. P Anjaneyulu - Director<BR>5. Y Janaki Ramaiah - Executive Director<BR>6. Pavansingh Thakur - Company Secretary & Compliance Officer<BR>7. M Sreerama Murthy - Independent Director<BR>8. G S R Anjaneyulu - Independent Director<BR>9. Yugandhar Sampath Kumar Sakhamuri - Independent Director<BR>10. Vijitha Gorrepati - Independent Director<BR>11. K. Srinivasa Rao - Alternate Director<BR>12. N. Nagendra Naidu - Independent Director<BR><BR>This team comprises a mix of executive, non-executive, and independent directors, contributing to the governance and strategic direction of the company.

Read More

Has Phyto Chem (I) declared dividend?

06-Jun-2025

Phyto Chem (India) Ltd has declared a 10% dividend, amounting to ₹1.00 per share, with an ex-date of September 25, 2014. However, the dividend yield is 0%, and total returns over recent periods have been largely negative, except for the 3-year and 4-year spans.

Phyto Chem (India) Ltd has declared a 10% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 10%<BR>- Amount per share: 1.0000<BR>- Ex-date: 25 Sep 14<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was -22.7%, the dividend return was 0%, resulting in a total return of -22.7%.<BR><BR>For the 1-year period, the price return was -8.67%, the dividend return was 0%, leading to a total return of -8.67%.<BR><BR>Over the 2-year period, the price return was -21.4%, with a dividend return of 0%, resulting in a total return of -21.4%.<BR><BR>In the 3-year period, the price return was 29.15%, the dividend return was 0%, which resulted in a total return of 29.15%.<BR><BR>For the 4-year period, the price return was 22.81%, the dividend return was 0%, leading to a total return of 22.81%.<BR><BR>In the 5-year period, the price return was -4.81%, with a dividend return of 0%, resulting in a total return of -4.81%.<BR><BR>Overall, while Phyto Chem (India) Ltd has declared a dividend, the total returns over various periods show significant fluctuations, with negative returns in most periods except for the 3-year and 4-year spans. The dividend yield remains at 0%, indicating that the dividend has not contributed to the overall returns in recent years.

Read More

Who are the peers of the Phyto Chem (I)?

03-Jun-2025

Phyto Chem (I) peers include P I Industries, UPL, Bayer CropSci., and others, with varying management and growth risks. Sharda Cropchem leads in 1-year returns at 102.43%, while Phyto Chem (I) has a return of -9.03%.

Peers: The peers of Phyto Chem (I) are P I Industries, UPL, Bayer CropSci., Sumitomo Chemi., Dhanuka Agritech, Sharda Cropchem, Rallis India, Bhagiradha Chem., and Bharat Rasayan.<BR><BR>Quality Snapshot: Excellent management risk is observed at Bayer CropSci., Dhanuka Agritech, and the rest. Good management risk is found at P I Industries, Sumitomo Chemi., Sharda Cropchem, and Bharat Rasayan, while Average management risk is present at UPL, Rallis India, and Bhagiradha Chem. In terms of growth, Excellent growth is seen at P I Industries, while Below Average growth is noted at UPL, Bayer CropSci., Sumitomo Chemi., Dhanuka Agritech, Sharda Cropchem, Rallis India, Bhagiradha Chem., and Bharat Rasayan. Capital Structure is Excellent for P I Industries, Bayer CropSci., Sumitomo Chemi., Dhanuka Agritech, Sharda Cropchem, and Bharat Rasayan, while Good capital structure is found at Bhagiradha Chem., and Below Average at UPL, Rallis India, and Phyto Chem (I).<BR><BR>Return Snapshot: The peer with the highest 1-year return is Sharda Cropchem at 102.43%, while Bharat Rasayan has the lowest at -12.17%. Phyto Chem (I) has a 1-year return of -9.03%, which is higher than Bharat Rasayan's but lower than Sharda Cropchem's. Additionally, UPL, Bharat Rasayan, and Phyto Chem (I) have negative six-month returns.

Read More

Is Phyto Chem (I) overvalued or undervalued?

09-Jun-2025

As of May 30, 2024, Phyto Chem (I) is considered risky and overvalued, with poor financial ratios indicating negative earnings performance and significant underperformance compared to industry peers and the Sensex.

As of 30 May 2024, the valuation grade for Phyto Chem (I) has moved from attractive to risky, indicating a significant deterioration in its financial standing. The company is currently assessed as overvalued. Key ratios reveal a PE ratio of -12.21, an EV to EBITDA of -22.40, and a ROE of -13.59%, all of which suggest poor profitability and negative earnings performance.<BR><BR>In comparison to its peers, Phyto Chem (I) stands out unfavorably; for instance, P I Industries has a PE ratio of 35.59, while UPL boasts a PE ratio of 38.74, both indicating a much stronger valuation. The negative ratios and the shift in valuation grade highlight that Phyto Chem (I) is not only underperforming relative to its industry peers but also reflects a concerning trend in its financial health. Additionally, the company's stock has underperformed the Sensex over various time frames, including a year-to-date decline of 17.85% compared to the Sensex's gain of 5.63%.

Read More

What is the technical trend for Phyto Chem (I)?

09-Jun-2025

As of May 27, 2025, Phyto Chem (I) has a bearish technical trend, supported by negative MACD indicators and moving averages, while the RSI shows no momentum and Dow Theory indicates no clear trend.

As of 27 May 2025, the technical trend for Phyto Chem (I) has changed from mildly bearish to bearish. The weekly and monthly MACD indicators are both bearish, reinforcing the negative sentiment. The daily moving averages also indicate a bearish stance. Although the Bollinger Bands show a mildly bearish trend on both weekly and monthly time frames, the KST is bearish as well. The RSI shows no signal, indicating a lack of momentum in either direction. Dow Theory confirms no trend on both weekly and monthly levels. Overall, the current technical stance is bearish with a moderate strength, driven primarily by the bearish MACD and moving averages.

Read More

How big is Phyto Chem (I)?

24-Jul-2025

As of 24th July, Phyto Chem (India) Ltd has a market capitalization of 13.00 Cr, with recent net sales of 14.09 Cr and a net profit loss of 1.00 Cr over the last four quarters. Shareholder's funds are 7.36 Cr, and total assets are valued at 31.17 Cr.

As of 24th July, <BR><BR>Market Cap: Phyto Chem (India) Ltd has a market capitalization of 13.00 Cr and is classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 14.09 Cr, while the sum of Net Profit for the same period reflects a loss of 1.00 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the latest annual data is March 2024. Shareholder's Funds stand at 7.36 Cr, and Total Assets are valued at 31.17 Cr.

Read More

Are Phyto Chem (I) latest results good or bad?

12-Aug-2025

Phyto Chem (India) reported disappointing results for June 2025, with net sales down 67.46% year-on-year and a negative profit after tax. MarketsMOJO has issued a 'Strong Sell' recommendation, indicating a negative outlook for the company.

Phyto Chem (India) has reported disappointing financial results for the quarter ending June 2025. The company experienced a significant decline in net sales, which dropped by 67.46% year-on-year, indicating serious challenges in its sales performance. Additionally, the profit after tax (PAT) was negative, reflecting a worsening financial situation.<BR><BR>Overall, the financial score of the company has deteriorated, and MarketsMOJO has issued a 'Strong Sell' recommendation on the stock. This suggests that the current outlook for Phyto Chem (I) is quite negative, and stakeholders should be cautious as the company navigates these difficulties.

Read More

When is the next results date for Phyto Chem (I)?

07-Nov-2025

Phyto Chem (I) will announce its results on 14 November 2025.

Phyto Chem (I) will declare its results on 14 November 2025.

Read More

Should I buy, sell or hold Phyto Chem (I)?

01-Dec-2025

How has been the historical performance of Phyto Chem (I)?

01-Dec-2025

Phyto Chem (I) has shown a declining trend in net sales and profitability, with net sales dropping from 44.49 Cr in Mar'21 to 14.08 Cr in Mar'25, resulting in significant losses and negative operating profit. The company's financial health has deteriorated, reflected in increasing losses and stagnant cash flow.

Answer:<BR>The historical performance of Phyto Chem (I) shows a declining trend in net sales and profitability over the years, with significant losses reported in the most recent fiscal year.<BR><BR>Breakdown:<BR>Phyto Chem (I) has experienced a consistent decline in net sales, dropping from 44.49 Cr in Mar'21 to just 14.08 Cr in Mar'25. This decline is mirrored in total operating income, which also fell from 44.49 Cr in Mar'21 to 14.08 Cr in Mar'25. The company's total expenditure has decreased from 42.28 Cr in Mar'21 to 15.42 Cr in Mar'25, yet it remains higher than the operating income, resulting in an operating profit (PBDIT) that has turned negative, reaching -1.34 Cr in Mar'25. Profit before tax has similarly worsened, moving from a profit of 0.47 Cr in Mar'21 to a loss of 1.05 Cr in Mar'25, leading to a profit after tax of -0.99 Cr for the same period. The earnings per share have also deteriorated, showing a loss of -2.3 in Mar'25 compared to a profit of 1.14 in Mar'21. On the balance sheet, total liabilities have decreased from 67.59 Cr in Mar'20 to 27.30 Cr in Mar'25, while total assets have similarly declined from 67.59 Cr to 27.30 Cr over the same period. The company has reported no cash inflow or outflow in recent years, indicating a stagnant cash position. Overall, Phyto Chem (I) has faced significant challenges, reflected in its declining sales, increasing losses, and deteriorating financial health.

Read More

Why is Phyto Chem (I) falling/rising?

04-Dec-2025

As of 04-Dec, Phyto Chem (India) Ltd's stock price is at Rs 28.83, down 4.47%, and has underperformed significantly with a 4.88% decline over the past week. Despite increased investor participation, the overall sentiment remains negative, indicating a challenging environment for the stock.

As of 04-Dec, Phyto Chem (India) Ltd's stock price is falling, currently at Rs 28.83, reflecting a decrease of Rs 1.35 or 4.47%. The stock has been underperforming significantly, with a decline of 4.88% over the past week, while the benchmark Sensex has only decreased by 0.53%. Additionally, the stock has experienced a consecutive fall over the last three days, accumulating a total drop of 7.8% during this period.<BR><BR>Today's trading performance indicates that the stock underperformed its sector by 5.3%. It reached an intraday low of Rs 28.8, which is a decline of 4.57%. The weighted average price suggests that more volume was traded closer to this low price, indicating a lack of buying interest at higher levels. While the stock's moving averages show it is higher than the 50-day and 100-day averages, it remains lower than the 5-day, 20-day, and 200-day moving averages, suggesting a bearish trend in the short to medium term.<BR><BR>Despite a rise in investor participation, with delivery volume increasing by 132.74% against the 5-day average, the overall sentiment appears negative, contributing to the stock's decline. The liquidity of the stock remains adequate for trading, but the current performance metrics indicate a challenging environment for Phyto Chem (India) Ltd.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

  • Poor long term growth as Net Sales has grown by an annual rate of -27.20% and Operating profit at -207.52% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at 2.33 times
  • The company has been able to generate a Return on Equity (avg) of 1.88% signifying low profitability per unit of shareholders funds
2

Flat results in Sep 25

3

Risky - Negative EBITDA

4

Underperformed the market in the last 1 year

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pesticides & Agrochemicals

stock-summary
Market cap

INR 12 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

31

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

2.75

stock-summary
Return on Equity

-12.69%

stock-summary
Price to Book

2.31

Revenue and Profits:
Net Sales:
4 Cr
(Quarterly Results - Sep 2025)
Net Profit:
-1 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
10.14%
0%
10.14%
6 Months
11.67%
0%
11.67%
1 Year
-9.93%
0%
-9.93%
2 Years
-15.8%
0%
-15.8%
3 Years
1.58%
0%
1.58%
4 Years
67.5%
0%
67.5%
5 Years
32.59%
0%
32.59%

Latest dividend: 1.0000 per share ex-dividend date: Sep-25-2014

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News

How has been the historical performance of Phyto Chem (I)?

Revenue and Profitability Trends

Over the past six years, Phyto Chem (I) has seen a significant decline in net sales, dropping from ₹59.11 crores in March 2019 to ₹14.08 crores in March 2025. The peak sales figure was recorded in 2019, followed by a steady downward trend with intermittent fluctuations. This contraction in revenue has been accompanied by a corresponding decrease in total operating income, reflecting the company’s challenges in maintaining its market position.

Profitability metrics reveal a mixed picture. Operating profit before other income (PBDIT excl OI) was positive from 2019 through 2023, peaking at ₹2.61 crores in March 2023, but turned negative in the latest two years, with a loss of ₹1.34 crores in March 2025. However, other income has provided s...

Read More
Announcements stock-summary

Results-Financial Results For SEP 30 2025 (Submission Of Unaudited Financial Results Of The Company For The Second Quarter And Half-Year Ended 30Th September 2025 - In Compliance Of Regulation 33 Of The SEBI (LODR) Regulations 2015-Regarding

14-Nov-2025 | Source : BSE

In furtherance to the Board meeting notice dated 06-11-2025 we wish inform you that at the meeting of Board of Directors of M/s.Phyto Chem (India) Limited held today i.e. on 14-11-2025 the Board has inter-alia considered and approved the unaudited financial results for the second quarter and half year ended 30-09-2025. The said unaudited financial results were reviewed by the audit committee and their after approved by the Board. Pursuat Regulation 33 of the SEBI(LODR) Regulations 2015 statement showing the unaudited financial results for the second quarter and half year ended on 30-09-2025 along with limited review report issued by the statutory auditors is attached herewith. The meeting commenced at 04:00PM and concluded at 08:15PM.

Board Meeting Outcome for Outcome Of Board Meeting- In Compliance Of Regulation 30(6) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Regarding

14-Nov-2025 | Source : BSE

Pursuant to the provisions of Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 we would like to inform you that at the meeting of Board of Directors of M/s Phyto Chem (India) Limited held on 14th November 2025 the Board has approved inter-alia the following items: 1. Approved the Unaudited Financial Results of the company for the Second Quarter and half- year ended 30th September 2025. The meeting commenced at 04:00 P.M. and concluded at 08:15 P.M. This is for your information and record.

Board Meeting Intimation for Intimation Of Board Meeting To Consider Unaudited Financial Results For The Second Quarter And Half Year Ended 30Th September 2025 Under Regulation 29 Of SEBI (LODR) Regulations 2015 - Regarding.

06-Nov-2025 | Source : BSE

Phyto Chem India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve We wish to inform you that the meeting of the Board of Directors of the Company will be held on Friday the 14th day of November 2025 at 04:00 P.M. at the Corporate office of the Company at No.8-3-229/23 First Floor Thaherville Yousufguda Checkpost Hyderabad - 500045 Telangana state inter-alia to consider and take on record the Unaudited Financial Results of the Company for the Second Quarter and half year ended 30th September 2025. In this connection as per the Companys Code of Conduct for Prohibition of Insider Trading the Trading Window for dealing in the securities of the Company is closed for all the Directors/ Officers/ Designated Employees of the Company from 01-10-2025 and will open after 48 hours of the announcement and intimation of the Results by the Company to the Stock Exchange on 14-11-2025. This communication has already been circulated to all the Directors/ Officers/ Designated Employees of the Company.

Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Phyto Chem (India) Ltd has declared 10% dividend, ex-date: 25 Sep 14

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-27.20%
EBIT Growth (5y)
-207.52%
EBIT to Interest (avg)
-0.39
Debt to EBITDA (avg)
4.65
Net Debt to Equity (avg)
2.75
Sales to Capital Employed (avg)
1.02
Tax Ratio
14.10%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
4.81%
ROCE (avg)
-2.55%
ROE (avg)
1.88%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
31
Price to Book Value
2.53
EV to EBIT
-13.04
EV to EBITDA
-15.46
EV to Capital Employed
1.41
EV to Sales
2.58
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-10.79%
ROE (Latest)
-12.69%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
Bullish
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 2 Schemes (0.19%)

FIIs

Held by 0 FIIs

Promoter with highest holding

Nayudamma Yarlagadda (7.87%)

Highest Public shareholder

Andhra Pradesh Industrial Development Corporation Limited (4.63%)

Individual Investors Holdings

49.36%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is -0.23% vs -39.39% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is -609.09% vs 168.75% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4.36",
          "val2": "4.37",
          "chgp": "-0.23%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.44",
          "val2": "0.56",
          "chgp": "-178.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.35",
          "val2": "0.38",
          "chgp": "-7.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.56",
          "val2": "0.11",
          "chgp": "-609.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-10.09%",
          "val2": "12.81%",
          "chgp": "-22.90%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is -34.63% vs 14.39% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 23.53% vs 29.17% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5.87",
          "val2": "8.98",
          "chgp": "-34.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.96",
          "val2": "-0.46",
          "chgp": "-108.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.67",
          "val2": "0.76",
          "chgp": "-11.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-1.04",
          "val2": "-1.36",
          "chgp": "23.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-16.35%",
          "val2": "-5.12%",
          "chgp": "-11.23%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -12.11% vs -33.96% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 109.82% vs -1,730.00% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "12.63",
          "val2": "14.37",
          "chgp": "-12.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.29",
          "val2": "0.03",
          "chgp": "-1,066.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.28",
          "val2": "1.63",
          "chgp": "-21.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.16",
          "val2": "-1.63",
          "chgp": "109.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2.30%",
          "val2": "0.21%",
          "chgp": "-2.51%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is -4.93% vs -44.66% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 70.27% vs -1,613.64% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "14.08",
          "val2": "14.81",
          "chgp": "-4.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.34",
          "val2": "-3.27",
          "chgp": "59.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.84",
          "val2": "2.05",
          "chgp": "-10.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.99",
          "val2": "-3.33",
          "chgp": "70.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-9.52%",
          "val2": "-22.08%",
          "chgp": "12.56%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Sep'25 - YoYstock-summary
Sep'25
Sep'24
Change(%)
Net Sales
4.36
4.37
-0.23%
Operating Profit (PBDIT) excl Other Income
-0.44
0.56
-178.57%
Interest
0.35
0.38
-7.89%
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.56
0.11
-609.09%
Operating Profit Margin (Excl OI)
-10.09%
12.81%
-22.90%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in quarter ended Sep 2025 is -0.23% vs -39.39% in Sep 2024

Direction Arrows
Standalone Net Profit

YoY Growth in quarter ended Sep 2025 is -609.09% vs 168.75% in Sep 2024

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary
Sep'25
Sep'24
Change(%)
Net Sales
5.87
8.98
-34.63%
Operating Profit (PBDIT) excl Other Income
-0.96
-0.46
-108.70%
Interest
0.67
0.76
-11.84%
Exceptional Items
0.00
0.00
Standalone Net Profit
-1.04
-1.36
23.53%
Operating Profit Margin (Excl OI)
-16.35%
-5.12%
-11.23%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is -34.63% vs 14.39% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is 23.53% vs 29.17% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
12.63
14.37
-12.11%
Operating Profit (PBDIT) excl Other Income
-0.29
0.03
-1,066.67%
Interest
1.28
1.63
-21.47%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.16
-1.63
109.82%
Operating Profit Margin (Excl OI)
-2.30%
0.21%
-2.51%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -12.11% vs -33.96% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 109.82% vs -1,730.00% in Dec 2023

Annual Results Snapshot (Standalone) - Mar'25stock-summary
Mar'25
Mar'24
Change(%)
Net Sales
14.08
14.81
-4.93%
Operating Profit (PBDIT) excl Other Income
-1.34
-3.27
59.02%
Interest
1.84
2.05
-10.24%
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.99
-3.33
70.27%
Operating Profit Margin (Excl OI)
-9.52%
-22.08%
12.56%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is -4.93% vs -44.66% in Mar 2024

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2025 is 70.27% vs -1,613.64% in Mar 2024

stock-summaryCompany CV
About Phyto Chem (India) Ltd stock-summary
stock-summary
Phyto Chem (India) Ltd
Micro Cap
Pesticides & Agrochemicals
Phyto Chem (India) Ltd was established in January, 1989 and is into the business of manufacturing & marketing of pesticides for agriculture sector. The Company is presently carrying on the business in two segments i.e. Pesticides Formulations and Real Estate Activities.
Company Coordinates stock-summary
Company Details
Survey No 628 Temple Street, Jinnaram Mandal Bonthapally Medak Telangana : 502313
stock-summary
Tel: 91-8458-275236
stock-summary
info@phytochemindia.com
Registrar Details
Bigshare Services Pvt Ltd , 306, Right Wing, Amrutha Ville, Opp. Yasodha Hospital, Raj Bhavan Road, Somajiguda, Hyderabad